Beacon Pointe Advisors LLC trimmed its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 69.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,472 shares of the company's stock after selling 21,808 shares during the quarter. Beacon Pointe Advisors LLC's holdings in American Healthcare REIT were worth $269,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of AHR. Geneos Wealth Management Inc. purchased a new position in shares of American Healthcare REIT in the 4th quarter valued at about $758,000. Principal Financial Group Inc. increased its holdings in shares of American Healthcare REIT by 54.1% in the 3rd quarter. Principal Financial Group Inc. now owns 9,488,750 shares of the company's stock valued at $247,654,000 after acquiring an additional 3,330,714 shares during the last quarter. Strategic Financial Concepts LLC purchased a new position in shares of American Healthcare REIT in the 4th quarter valued at about $331,000. Arkadios Wealth Advisors increased its holdings in shares of American Healthcare REIT by 46.7% in the 4th quarter. Arkadios Wealth Advisors now owns 45,451 shares of the company's stock valued at $1,292,000 after acquiring an additional 14,464 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of American Healthcare REIT by 15.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 917,636 shares of the company's stock valued at $23,950,000 after acquiring an additional 125,641 shares during the last quarter. 16.68% of the stock is owned by institutional investors and hedge funds.
American Healthcare REIT Stock Performance
American Healthcare REIT stock traded up $2.73 during mid-day trading on Friday, reaching $34.94. 2,431,093 shares of the company were exchanged, compared to its average volume of 1,814,925. American Healthcare REIT, Inc. has a twelve month low of $13.67 and a twelve month high of $35.10. The firm's 50-day simple moving average is $30.20 and its two-hundred day simple moving average is $28.81. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. The firm has a market cap of $5.51 billion, a PE ratio of -72.79, a price-to-earnings-growth ratio of 1.57 and a beta of 1.40.
American Healthcare REIT (NYSE:AHR - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.01. American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. The company had revenue of $540.60 million during the quarter, compared to analysts' expectations of $542.32 million. During the same period last year, the firm earned $0.30 EPS. The firm's revenue for the quarter was up 8.2% on a year-over-year basis. Equities analysts predict that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.
American Healthcare REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 17th. Shareholders of record on Monday, March 31st were given a dividend of $0.25 per share. The ex-dividend date was Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.86%. American Healthcare REIT's payout ratio is -370.37%.
Analysts Set New Price Targets
A number of research firms have recently commented on AHR. Royal Bank of Canada reiterated an "outperform" rating and issued a $34.00 price objective on shares of American Healthcare REIT in a report on Wednesday, March 19th. Citigroup reiterated an "outperform" rating on shares of American Healthcare REIT in a report on Tuesday, March 4th. Jefferies Financial Group started coverage on American Healthcare REIT in a report on Monday, April 28th. They issued a "buy" rating and a $37.00 price objective on the stock. Morgan Stanley upped their target price on American Healthcare REIT from $36.00 to $37.00 and gave the company an "overweight" rating in a research report on Tuesday, March 25th. Finally, JMP Securities set a $35.00 target price on American Healthcare REIT in a research report on Tuesday, March 4th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $33.86.
Read Our Latest Stock Analysis on American Healthcare REIT
About American Healthcare REIT
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Articles

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.